We have received the following stock update from Teva:
25mg capsules: in stock
50mg capsules: out of stock. Expected back at the end of December 2020
100mg capsules: out of stock. Expected back at the end of November 2020
Dr Reddy's Laboratories (UK) Ltd have stopped making their version of zonisamide capsules. This applies to all strengths.
Zonisamide capsules made by Actavis/Accord are out of stock in all strengths. Actavis/Accord do not know when they will be back in stock, although they have told us it is likely to be at least 2 to 3 months.
Update 17 July:
Vimpat 50mg tablets are back in stock. It may take a few days for stock to reach wholesalers, but they should be readily available by 22 July.
Original story 26 June: UCB, the makers of Vimpat, have told us they expect to run out of stock of Vimpat (lacosamide) 50mg tablets in the next 3 weeks. The tablets are likely to be out of stock for a period of 2-3 weeks. This is due to a manufacturing delay.
Update on 6 July 2020
Teva topiramate tablets are still out of stock. They are due back in stock between October and December 2020.
Update on 6 July 2020
Accord topiramate tablets are back in stock in all strengths. They are now supplied in pots instead of blister packs.
Update on 25 June 2020
We have received confirmation that Convulex (valproic acid) capsules are back in stock.
Update on 25 June 2020
Phenytoin sodium NRIM 100mg capsules are still out of stock. We will update this page when we know more about when they may be back in stock.
Update on 19 June 2020
Pfizer expects to have Epanutin Infatabs back in stock from the end of July 2020. They are continuing to supply Dilantin Infatabs from Canada to cover this shortage.
Update on 10 June 2020
Epanutin oral suspension is back in stock.
